UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1943-01-01

Employees: 8.1K

Market Cap: -

Website: http://www.utsouthwestern.edu

Clinical Trials

The Genetic, Protein, and Lipid Basis of Variation in Cholesterol Efflux

Active, not recruiting

Conditions: Lipid Metabolism Disorders

First Posted Date: 2019-08-19

Last Posted Date: 2024-04-10

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 180

Registration Number: NCT04061018

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Innovatively Increasing PCP Prescribing of Buprenorphine: Measurement Based Care and Integrated Electronic Solution

Completed

Conditions: Opioid Abuse and Addiction

First Posted Date: 2019-08-16

Last Posted Date: 2024-06-18

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 75

Registration Number: NCT04059016

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity

Early Phase 1

Active, not recruiting

Conditions: Left Sided Breast Cancer
Thoracic Cancer

Interventions: Diagnostic Test: [1-13C]pyruvate along with MRI imaging

First Posted Date: 2019-08-05

Last Posted Date: 2023-08-23

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 10

Registration Number: NCT04044872

Locations: 🇺🇸
Department of Radiation Oncology; UT Southwestern Medical Center, Dallas, Texas, United States

PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer

Early Phase 1

Completed

Conditions: Ovarian Cancer
Breast Cancer

Interventions: Drug: Lynparza

First Posted Date: 2019-08-01

Last Posted Date: 2023-03-20

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 14

Registration Number: NCT04041128

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

A Phase I Dose Escalation Study of Single Fraction Ablative Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer

Phase 1

Active, not recruiting

Conditions: Breast Cancer

Interventions: Radiation: Radiomics on MRI

First Posted Date: 2019-07-31

Last Posted Date: 2024-06-21

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 45

Registration Number: NCT04040569

Locations: 🇺🇸
University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States

Lessons on Urethral Lidocaine in Urodynamics

Phase 4

Completed

Conditions: Cystocele
Uterine Prolapse
Pelvic Organ Prolapse
Vaginal Vault Prolapse
Urinary Incontinence
Urethra Issue
Vaginal Prolapse
Pelvic Floor Disorders

Interventions: Drug: Water-Based Vaginal Lubricant
Drug: lidocaine topical

First Posted Date: 2019-07-30

Last Posted Date: 2023-08-01

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 63

Registration Number: NCT04038099

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Inflammatory Biomarkers to Diagnose and Monitor Diabetic Foot Osteomyelitis

Completed

Conditions: Diabetic Foot Ulcer

First Posted Date: 2019-07-19

Last Posted Date: 2023-07-24

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 455

Registration Number: NCT04025853

Locations: 🇺🇸
UT Southwestern Medical Center at Dallas, Dallas, Texas, United States

Epidural Placement Using Handheld Ultrasound Device vs. Traditional Landmark Palpation

Not Applicable

Terminated

Conditions: Labor Pain

Interventions: Other: Landmark palpation
Other: Ultrasound image guidance

First Posted Date: 2019-07-15

Last Posted Date: 2022-06-01

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 74

Registration Number: NCT04020042

Locations: 🇺🇸
Parkland Health Hospital System, Dallas, Texas, United States

Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer

Phase 2

Active, not recruiting

Conditions: Lung Cancer Stage III
Non Small Cell Lung Cancer

Interventions: Radiation: Thoracic RT and Durvalumab
Drug: Consolidative Durvalumab

First Posted Date: 2019-07-01

Last Posted Date: 2024-08-28

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 50

Registration Number: NCT04003246

Locations: 🇺🇸
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States

Developing and Implementing an Adolescent Suicide Prevention Program in a Community Mental Health Setting

Not Applicable

Completed

Conditions: Suicidal Ideation
Suicide, Attempted

Interventions: Behavioral: Suicide Prevention Intensive Outpatient Program

First Posted Date: 2019-06-20

Last Posted Date: 2021-03-30

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 102

Registration Number: NCT03992391

Locations: 🇺🇸
Metrocare Services, Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy